Showing results (1571-1580 of 1,826) with videos related to

Sort By:
Pageof 183
Bone Marrow Transplantation|October 17, 2019
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
Bone Marrow Transplantation|October 2, 2021
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMTStavroula Masouridi-Levrat, Eduardo Olavarria, Simona Iacobelli, et al.
Nature Medicine|January 17, 2024
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphomaFrederick L Locke, Simone Filosto, Justin Chou, et al.
Bone Marrow Transplantation|March 5, 2024
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMTAnna Sureda, Paul A Carpenter, Andrea Bacigalupo, et al.
The Lancet. Oncology|December 8, 2015
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trialMichael L Wang, Hun Lee, Hubert Chuang, et al.
Bone Marrow Transplantation|December 20, 2017
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMTGwendolyn van Gorkom, Michel van Gelder, Dirk-Jan Eikema, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2016
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung DiseaseJuliane Rieber, Nasrin Abbassi-Senger, Sonja Adebahr, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Bone Marrow Transplantation|August 14, 2024
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMTRazan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, et al.
The American Journal of Pathology|November 29, 2023
Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Jonas C Schupp, et al.
Pageof 183